Company information
- Ticker
- ESLOY
- Country
- United States
ESSILORLUXOT-UNSPON ADR Business Summary
EssilorLuxottica (ESLOY) operates as a vertically integrated global powerhouse in the design, manufacture, and distribution of ophthalmic lenses, frames, and sunglasses. The company generates revenue through two primary segments: Professional Solutions, which serves as a wholesale provider to independent eyecare professionals and third-party retailers, and Direct to Consumer, which encompasses a massive global retail network including banners like LensCrafters, Sunglass Hut, and Target Optical, alongside a growing e-commerce footprint. Its revenue model is increasingly driven by high-tech innovation, specifically through its myopia management portfolio and AI-powered smart glasses developed in partnership with Meta. Within the competitive landscape, EssilorLuxottica maintains a dominant market-leading position, significantly outpacing direct rivals such as Safilo Group, Hoya Corporation, Carl Zeiss AG, and Kering Eyewear by controlling the entire value chain from lens technology to final retail sale. The company was formed through the 2018 merger of the French lens pioneer Essilor and the Italian eyewear giant Luxottica, the latter founded by the late Leonardo Del Vecchio. Current leadership is headed by Chairman and CEO Francesco Milleri, a former business consultant and technology entrepreneur with an MBA from Bocconi University and specialized training from NYU Stern, who has been instrumental in the group's pivot toward MedTech and wearables. He is supported by Deputy CEO Paul du Saillant, a veteran executive with decades of experience at Essilor, and CFO Stefano Grassi. The company’s strategic direction remains closely tied to its largest shareholder, Delfin S.à.r.l (the Del Vecchio family holding company), which maintains a stake of approximately 32%. The board also features prominent independent directors such as Lead Director Jean-Luc Biamonti and Marie-Christine Coisne-Roquette, ensuring a blend of luxury, healthcare, and industrial expertise.